John Mohr & Sons v. VACUDYNE CORPORATION

354 F. Supp. 1113, 177 U.S.P.Q. (BNA) 307, 1973 U.S. Dist. LEXIS 15078
CourtDistrict Court, N.D. Illinois
DecidedFebruary 2, 1973
Docket71 C 644
StatusPublished
Cited by5 cases

This text of 354 F. Supp. 1113 (John Mohr & Sons v. VACUDYNE CORPORATION) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
John Mohr & Sons v. VACUDYNE CORPORATION, 354 F. Supp. 1113, 177 U.S.P.Q. (BNA) 307, 1973 U.S. Dist. LEXIS 15078 (N.D. Ill. 1973).

Opinion

MEMORANDUM OPINION AND ORDER.

BAUER, District Judge.

This cause comes on the motions of both plaintiff and defendants for summary judgment.

The plaintiff, John Mohr & Sons (“Mohr”) is an Illinois corporation having its principal place of business in Chicago, Illinois. The defendants are Vacudyne Corporation (“Vacudyne”) and Arthur N. Lederman, its president. Vacudyne, an Illinois corporation has its registered office in Chicago, Illinois and its principal place of business in Chicago Heights, Illinois.

This is an action for the infringement of plaintiff’s U. S. Patent # 3,131,700. The jurisdiction of this Court is based on 28 U.S.C. § 1338(a).

The parties have stipulated to the following facts:

(a) The patent in suit contains two claims, both method claims.

(b) Defendants, who have their manufacturing plant and headquarters in the United States, solicit orders in foreign countries, including orders for machines capable of performing the method described and claimed in the patent in suit.

(c) Responsibility for the solicitation of said orders in foreign countries originates in Defendants’ regular place of business in the United States (Chicago Heights, Illinois).

(d) The orders solicited from customers located in foreign countries are accepted in Defendants’ offices in the United States.

(e) The alleged infringers completely fabricate and assemble in the United States a machine capable of performing the patented method.

(f) The alleged infringers test the operation of at least the components of the equipment in the United States, but carry out no tests in the United States in which tobacco or hogsheads of tobacco are used.

*1115 (g) The sale, including passage of title, of a machine capable of performing the method disclosed and claimed in the United States patent in suit occurs in the United States.

(h) Complete operating instructions, including written instructions which advise the foreign purchaser as to the operation of the machine, including operation for carrying out the method steps recited in the claims of the patent in suit, accompany the equipment shipped from the United States to the foreign purchaser for use in that foreign country.

(i) Employees of the alleged infringer are sent from the United States headquarters to supervise and instruct the foreign purchaser in the installation of the equipment, and its operation in a manner which includes the steps called for in the claims of the patent in suit.

(j) Employees of the alleged infringer are sent from the United States at its expense to assist the foreign customer when operating troubles are encountered subsequent to installation.

(k) No foreign patents are involved in this litigation, and Defendants are not charged with infringement of any foreign patent.

(l) Defendants’ equipment, which includes probe assemblies, is shipped to foreign purchasers in a partially disassembled state to protect component elements of the equipment, including the probe assemblies, and to conserve shipping space.

The stipulated facts effectively eliminate all material factual issues in this case. The stipulation of facts was intended to permit the framing of a single question of law. This Court is in accord with the parties conclusion that there remains a single question of law which will be determinative of all issues in this case including the question of whether Defendants in any manner infringed any of the claims of the Plaintiff’s method patent.

The sole and controlling question of law in this case has been stated by the parties as follows:

“Does the ‘manufacture’ and ‘sale’ in the United States of processing equipment for use only in foreign countries, and used only in foreign countries, constitute infringement of a method claim of a United States patent, conceding that the equipment is ‘capable’ of carrying out the process defined by the method claim of that United States patent?”

Thus, the question of law to be ruled upon by this Court is whether there can be infringement of a method claim of a United States patent by one who manufactures in the United States equipment capable of carrying out the claimed method and who sells this equipment to a foreign customer for use exclusively in the foreign country. Plaintiff contends that such activities constitute infringement of the method claim of the United States patent. Defendant’s position is that there cannot be infringement of the United States method patent under such a factual situation.

It is the opinion of this Court that no United States method patent can be infringed without carrying out that method in the United States.

It is a fundamental rule of patent law that in an action brought by a patentee charging infringement of Letters Patent of the United States, the burden of proving the infringement is on the patentee. Price v. Kelly, 154 U.S. 669, 14 S.Ct. 1208, 26 L.Ed. 634 (1881). Title 35 § 271 of the U.S.C. sets forth patent infringement as:

“(a) Except as otherwise provided in this title, whoever without authority makes, uses or sells any patented invention, within the United States during the term of the patent therefor, infringes the patent.
(b) Whoever actively induces infringement of a patent shall be liable as an infringer.
*1116 (c) Whoever sells a component of a patented machine, manufacture, combination or composition, or a material or apparatus for use in practicing a patented process, constituting a material part of the invention, knowing the same to be especially made or especially adapted for use in an infringement of such patent, and not a staple article or commodity of commerce suitable for substantial noninfringing use, shall be liable as a contributory infringer.”

The express language of the statute sets forth that infringement must be by making, using, or selling the patented invention within the United States.

In the instant action the patented invention is a method. It seems obvious that a method patent can only be infringed by practice of the claimed method within the United States. Both parties have stipulated that the instant action does not involve a use of a method patent in the U.S. The plaintiff alleges that the infringing act is the Defendants’ sale to foreign users for use solely in foreign countries, of a machine “capable” of carrying out the method steps of the patent in question. The plaintiff does not cite any case or statutory law to support his contention that such a sale infringes a method patent. Further the Court after an examination of the relevant case law has not found any cases which would support the Plaintiff’s contention.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cardiac Pacemakers, Inc. v. St. Jude Medical, Inc.
576 F.3d 1348 (Federal Circuit, 2009)
Enka BV of Arnhem, Holland v. EI DU PONT, ETC.
519 F. Supp. 356 (D. Delaware, 1981)
Enka B. V. v. E. I. Du Pont De Nemours & Co.
519 F. Supp. 356 (D. Delaware, 1981)
Griffin v. Keystone Mushroom Farm, Inc.
453 F. Supp. 1283 (E.D. Pennsylvania, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
354 F. Supp. 1113, 177 U.S.P.Q. (BNA) 307, 1973 U.S. Dist. LEXIS 15078, Counsel Stack Legal Research, https://law.counselstack.com/opinion/john-mohr-sons-v-vacudyne-corporation-ilnd-1973.